Magnar Ervik

891 total citations
29 papers, 752 citations indexed

About

Magnar Ervik is a scholar working on Analytical Chemistry, Spectroscopy and Animal Science and Zoology. According to data from OpenAlex, Magnar Ervik has authored 29 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Analytical Chemistry, 12 papers in Spectroscopy and 5 papers in Animal Science and Zoology. Recurrent topics in Magnar Ervik's work include Analytical Methods in Pharmaceuticals (11 papers), Analytical Chemistry and Chromatography (10 papers) and Pharmacological Effects and Assays (5 papers). Magnar Ervik is often cited by papers focused on Analytical Methods in Pharmaceuticals (11 papers), Analytical Chemistry and Chromatography (10 papers) and Pharmacological Effects and Assays (5 papers). Magnar Ervik collaborates with scholars based in Sweden, Switzerland and United States. Magnar Ervik's co-authors include Martin Ahnoff, Per-Olof Lagerström, C G Regårdh, Lars Johansson, L. Jordö, Kurt‐Jürgen Hoffmann, Jörgen Vessman, Jenny Hällgren, G. Johnsson and Bengt‐Arne Persson and has published in prestigious journals such as Analytical Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

Magnar Ervik

29 papers receiving 629 citations

Peers

Magnar Ervik

AC

SPECT

PHARM

CCM

PHARM

William D. Mason United States

M.T. Rosseel Belgium

Sandra R. Harapat United States

F. Pommier Switzerland

B Flouvat France

Peter J. Meffin United States

Gwyn H. Evans United States

RG Shanks United Kingdom

H. Spahn Germany

Matthew J. Cyronak United States

William D. Mason United States

Magnar Ervik

263 ×0.8

AC

154 ×0.8

SPECT

185 ×1.1

PHARM

92 ×0.6

CCM

106 ×1.1

PHARM

Citations per year, relative to Magnar Ervik Magnar Ervik (= 1×) peers William D. Mason

Countries citing papers authored by Magnar Ervik

Since Specialization

Citations

This map shows the geographic impact of Magnar Ervik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnar Ervik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnar Ervik more than expected).

Fields of papers citing papers by Magnar Ervik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnar Ervik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnar Ervik. The network helps show where Magnar Ervik may publish in the future.

Co-authorship network of co-authors of Magnar Ervik

This figure shows the co-authorship network connecting the top 25 collaborators of Magnar Ervik. A scholar is included among the top collaborators of Magnar Ervik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnar Ervik. Magnar Ervik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Persson, Bengt‐Arne, et al.. (2005). Interference from a glucuronide metabolite in the determination of ramipril and ramiprilat in human plasma and urine by gas chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 40(3). 794–798. 21 indexed citations

2.

Ervik, Magnar, et al.. (1997). Determination of low levels of poly(ethylene glycol) 400 in plasma and urine by capillary gas chromatography-selected ion-monitoring mass spectrometry after solid-phase extraction. Journal of Chromatography B. 700. 93–100. 1 indexed citations

3.

Ervik, Magnar, et al.. (1997). Determination of low levels of poly(ethylene glycol) 400 in plasma and urine by capillary gas chromatography-selected ion-monitoring mass spectrometry after solid-phase extraction. Journal of Chromatography B Biomedical Sciences and Applications. 700(1-2). 93–100. 8 indexed citations

4.

Nordström, Marie, et al.. (1993). Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.. Journal of Pharmacology and Experimental Therapeutics. 266(1). 147–152. 17 indexed citations

5.

Rydén, Lars, et al.. (1990). Pronounced Accumulation of Metoprolol in Ischemic Myocardium After Coronary Venous Retroinfusion. Journal of Cardiovascular Pharmacology. 15(1). 22–28. 19 indexed citations

6.

Larsson, Maria E. H., et al.. (1988). Comparison between methylphenidate and placebo as adjuvant in care and rehabilitation of geriatric patients.. PubMed. 2(2). 53–9. 6 indexed citations

7.

Åblad, Bengt, Tommy Abrahamsson, Jan‐Arne Björkman, et al.. (1987). Cardiac Antiischemic Effect of Metoprolol. Journal of Cardiovascular Pharmacology. 10. S117–125. 11 indexed citations

8.

Åblad, Bengt, Tommy Abrahamsson, Jan‐Arne Björkman, et al.. (1987). Cardiac Antiischemic Effect of Metoprolol. Journal of Cardiovascular Pharmacology. 10. S117–125. 2 indexed citations

9.

Ervik, Magnar, et al.. (1986). Determination of metoprolol in plasma and urine using high-resolution gas chromatography and electron-capture detection. Journal of Chromatography B Biomedical Sciences and Applications. 381(1). 168–174. 61 indexed citations

10.

Abrahamsson, Tommy, G. Adler, Jan‐Arne Björkman, et al.. (1985). The distribution of atenolol and metoprolol into ischemic and non-ischemic myocardium. Journal of Molecular and Cellular Cardiology. 17. 52–52. 2 indexed citations

11.

Ahnoff, Martin, et al.. (1985). Review. Drug level monitoring: Cardiovascular drugs.. Journal of Chromatography A. 340. 73–138. 26 indexed citations

12.

Ahnoff, Martin, Magnar Ervik, Per-Olof Lagerström, Bengt‐Arne Persson, & Jörgen Vessman. (1985). Drug level monitoring: cardiovascular drugs. Journal of Chromatography B Biomedical Sciences and Applications. 340. 73–138. 36 indexed citations

13.

Ervik, Magnar & Svein M. Fikke. (1982). Development of a Mathematical Model to Estimate Ice Loading on Transmission Lines by Use of General Climatological Data. IEEE Power Engineering Review. PER-2(6). 36–37. 1 indexed citations

14.

Ervik, Magnar, et al.. (1982). Assay of prenalterol in plasma and urine by gas chromatography—mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 229(1). 87–94. 14 indexed citations

15.

Ervik, Magnar & Svein M. Fikke. (1982). Development of a Mathematical Model to Estimate Ice Loading on Transmission Lines by Use of General Climatological Data. IEEE Transactions on Power Apparatus and Systems. PAS-101(6). 1497–1503. 14 indexed citations

16.

Ervik, Magnar. (1981). Vibration Damping on Long Fjord Crossings Theoretical Investigations. IEEE Transactions on Power Apparatus and Systems. PAS-100(4). 2149–2158. 9 indexed citations

17.

Ervik, Magnar, et al.. (1981). Selected ion monitoring of metoprolol and two metabolites in plasma and urine using deuterated internal standards. Journal of Mass Spectrometry. 8(7). 322–326. 42 indexed citations

18.

Hoffmann, Kurt, C G Regårdh, Mattias Aurell, Magnar Ervik, & L. Jordö. (1980). The Effect of Impaired Renal Function on the Plasma Concentration and Urinary Excretion of Metoprolol Metabolites. Clinical Pharmacokinetics. 5(2). 181–191. 44 indexed citations

19.

Ervik, Magnar, et al.. (1980). Electron-capture—gas chromatographic determination of atenolol in plasma and urine, using a simplified procedure with improved selectivity. Journal of Chromatography B Biomedical Sciences and Applications. 182(3). 341–347. 49 indexed citations

20.

Ervik, Magnar. (1975). Quantitative determination of metoprolol in plasma and urine by gas chromatography. Acta Pharmacologica et Toxicologica. 36(s5). 136–144. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact